The FDA approved oveporexton for narcolepsy type 1 in adults, marking the first orexin receptor agonist targeting the underlying biological cause of narcolepsy.
|Articles|September 1, 2005
Perchance to Dream
Author(s)Michael G. Pierik, MD
How to lessen insomnia during a sleep study.
Advertisement
Tossing and turning because of unfamiliar bedding in a strange environment can affect the validity of sleep study results. One way to reduce this effect is to have patients use their own pillows and blankets.
- Michael G. Pierik, MD
Wakefield, RI
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Patient Care Online
1
ASH Raises Ferritin Thresholds for Diagnosing Iron Deficiency
2
FDA Approves Finerenone for CKD Associated With Type 1 Diabetes
3
Combating Prostate Cancer Misconceptions in Primary Care: An Expert Discussion
4
FDA Grants Priority Review to Zasocitinib for Plaque Psoriasis
5